EIF4EBP1 and hepatocellular carcinoma: Since this inhibitor negatively regulates CD44 protein expression possibly through suppressing phosphorylation of 4EBP-1 in CD44high HCC cells (Figure 2 and Supplementary Figure 3), we first evaluated the CD44 and mTOR pathways in HCC cells with acquired sorafenib resistance.